Tibor T. Glant, MD, PhD

Tibor T. Glant, MD, PhD, received his MD and PhD degrees from the Medical University of Debrecen, Hungary, and his DMSc (Doctor of Medical Sciences) degree from the Hungarian Academy of Sciences  in Budapest, Hungary. Glant completed his medical residency in pathology and internal medicine/rheumatology and was involved in clinical practice, teaching and research at the Medical University of Debrecen, Hungary. In 1983, he was invited to conduct full-time research in the Joint Diseases Laboratory of Shriners Hospital in Montreal, Canada, where he serendipitously discovered proteoglycan-induced arthritis, a mouse model of human rheumatoid arthritis. Glant was awarded the Carol-Nachman Prize in Rheumatology, an international award, in 1995 for his work on this new animal model. Glant joined Rush in 1988 as associate professor of orthopedic surgery and biochemistry. Since 1997, he has been the Jorge O. Galante Professor of Orthopedic Surgery and director of the Section of Molecular Medicine in the Department of Orthopedic Surgery. Glant’s research revolves around the immunology, genetics and epigenetics of rheumatoid arthritis and spondyloarthritis. For over 25 years, his research has been funded by the National Institutes of Health (NIH), the National Arthritis Foundation and the Grainger Foundation. He has authored over 200 peer-reviewed articles and several book chapters. In 2007, he was elected member of the Hungarian Academy of Sciences. Glant has been serving as a member of numerous scientific review groups of the NIH, and as an editorial board member of several journals since 1995.